Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 500-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

By Masuda Hiroko   Masuda Norikazu   Kodama Yoshinori   Ogawa Masami   Karita Michiko   Yamamura Jun   Tsukuda Kazunori   Doihara Hiroyoshi   Miyoshi Shinichiro   Mano Masayuki   Nakamori Shoji   Tsujinaka Toshimasa  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 911-917

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite